Cordlife launches upgraded cord blood facility in Singapore after Ministry of Health approval.

Cordlife Group Limited has launched an upgraded cord blood processing and storage facility in Singapore, following Ministry of Health approval to resume operations. The 5,400 square feet facility features advanced monitoring systems and enhanced operational protocols. Cordlife aims to rebuild trust after past issues and has partnered with China's Shandong Qilu Stemcell Engineering Co., Ltd. to bolster capabilities, allowing up to 30 new cord blood units per month.

September 17, 2024
12 Articles

Further Reading